Mod 1 Lecture 1 Flashcards

1
Q

what is the common venous clot

A

DVT -> PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is virchows triad

A

stasis
vessel wall injury
hypercoaguability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the treatment for DVT

A

anticoagulant drugs or thrombolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are arterial clots

A

medium sized arteries (carotid, optical)
endothelial damage in atherosclerosis, states of low flow -> thrombosis/emboli
emboli from heart in Afib; MI and stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what do arterial clots block

A

block delivery of oxygen (Painful)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the treatment of arterial clots

A

anti-platelet drugs and thombolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the goal of antiplatelets

A

slow platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the goal of anticoagulation agents

A

slow down clotting via interference with fibrin formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the goal of fibrinolytics

A

dissolve clots
antidotes exist for most anticoagulation meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the goal of anticoagulants and antithrombotic meds

A

prevention of heart attack, stroke, PE or DVT
also, prevent complications of Afib, CHF, and genetic or acquired hypercoagulability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the purpose of thomboxane A2

A

causes shape change and activation of GPIIB/IIIa receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the purpose of ADP

A

causes release of granules and activation of GPIIb/IIIa receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the purpose of GPIIb/IIIa receptors

A

when active, bind fibrinogen and crosslink platelets together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what fibrinolyzes the clot after platelet aggregation

A

plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what type of agent are aspirin, clopidogrel, abciximab

A

anti-platelet agents that prevent platelet activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what type of agents are heparin and warfarin

A

classical anticoagulants - prevent formation of fibrin clots (venous thrombus )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what type of agents is dabigatran

A

“new” thrombin inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what type of agent is tPA and anistreplase

A

fibrinolytic agents - break down existing clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what antiplatelet drugs are P2Y12 ADP receptor inhibitors (platelet antagonists)

A

clopidogrel (Plavix)
Prasugrel (Effient)
Ticlopidine (Ticlid)
Ticagrelor (Brilinta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are antiplatelets that are GPIIb/IIIa receptor inhibitors

A

abciximab (reoPro)
Eptifbatide (integrilin)
Tirofiban (aggrastat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are antiplatelets that are phosphodiesterase inhibitors

A

dipyridamole (Persantine)
Cilostazol (pletal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the MOA of aspirin

A

inhibits COX-1 IRREVERSIBLY
inhibition of platelet aggregation is the result

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is COX1 important for

A

key enzyme involved in the synthesis of platelet thromboxane A2 (prostaglandin pathway)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

when is aspirin indicated

A

primary prevention of heart attack and stroke
used for clot risk reduction after surgery
secondary prevention in pts with hx of CAD, DM, PVD, CVA, TIA
and DAPT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what does DAPT stand for

A

Dual Anti-platelet therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

when is DAPT recommended

A

after CABG, PCI (stent), stroke, TIA for 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

when is aspirin contraindicated?

A

bleeding risk (elderly, GI)
tinnitus (makes it worse)
perioperative: intracranial, intramedullary or posterior eye surgeries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

when should ASA 81 be discontinued peri-operatively

A

intracranial, intramedullary or posterior eye surgeries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is the MOA of Clopidogrel

A

Irreversibly blocks P2Y12 ADP receptors on platelet surface -> decrease ADP-stimulated aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

when does clopidogrel have reduced effectiveness

A

in patients who are poor metabolizers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what is the goal of clopidogrel

A

prevent further atherosclerotic events in MI and unstable angina
ACS and coronary angioplasty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

when is clopidogrel used

A

DAPT with 81mg ASA for Bare-metal stent (BMS), Drug eluting stent (DES), Acute coronary stent (ACS) and TIA/minor ischemic stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

how long is clopidogrel typically used

A

usually no longer than 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what is a DAPT score greater than or equal to 2 mean

A

favorable benefit/risk ratio for prolonged DAPT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

a DAPT score of less then 2 is associated with what

A

in-favorable benefit/risk ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

when should P2Y12 ADP receptor inhibitors be avoided

A

episodes of active bleeding
history of bleeding (GI, Intracranial)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

what is Clopidogrel used to prevent

A

CVD event in recent MI, CVA, RAP and prevent thrombosis in ACS with or without PCI stent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what is generally the first-line antiplatelet drug

A

Clopidogrel (plavix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

when should Clopidogrel be stopped prior to a lifesaving surgery

A

at least 5 days prior to surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

what is the medication when Clopidogrel does not work or the patient is a fast metabolizer

A

Ticagrelor (brilinta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

what is Ticagrelor

A

ONLY REVERSIBLE P2Y12 inhibitor
taken with low dose aspirin (DAPT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

what is Parsugrel (effient)

A

second P2Y12 inhibitor
approved in aCS and after MI
increased antiplatelet activity, so less CV death, MI, stroke
increased risk of bleeding, especially >75yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

when should parsugrel be avoided

A

history of bleeding (especially > 75yo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

what is the risk of Ticlopidine (ticlid)

A

risk of thrombocytopenia, agranulocytosis and TTP (Thrombotic thrombocytopenia purpura)

No longer sold in the US due to serious life threatening hematologic AE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

what do GPIIb/IIIa inhibitors bind to

A

bind to platelet GPIIb/IIIa receptor complex
bind to vWF and fibroinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

what is the purpose of GPIIb/IIIa inhibitors

A

inhibit action of platelet aggregation
use with ASA and heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

when are GPIIb/IIIa inhibitors used

A

with ASA and heparin during balloon angioplasty, coronary stent placement, PCI, if needed to prevent further clot formation

48
Q

what is a Humanized monoclonal antibody

A

Abciximab (ReoPro)
administered IV

49
Q

what is the adverse effects of abciximab

A

bleeding

50
Q

what is tirofibran used for

A

reduces rate of thrombotic CV events VERY RARELY USED
can be used in NSTEMI with PCI

IV infusion

51
Q

what is the risk of Tirofibran use

A

hx of bleeding

52
Q

what needs to be monitored with Tirofibran

A

aPPT

53
Q

what is inhibited with prosphodiesterase inhibitors

A

inhibit conversion of cAMP to AMP
inhibit platelet aggregation
encourages vasodilation - can cause rebound headaches

54
Q

what medication is used for stress tests to induce reflex tachycardia

A

Dipyridamole (persantine)
causes vasodilation

55
Q

when isDipyridamole used

A

rarely used, but when used, is in fixed combo with ASA (Aggrenox) for secondary stroke prevention

56
Q

when is Cilostazol used

A

intermittent claudication (legs) in PVD

57
Q

what is the effect of cilostazol

A

vasodilatory and anti-platelet effects
increasses HDL cholesterol

58
Q

when is cilostazol contraindicated

A

heart failure

59
Q

what are the adverse effects of Cilostazol

A

headache and GI upset and many drug interactions (CYP inhibitor)

60
Q

what are platelet activating supplements

A

fish oil
dong quai
garlic, ginger, gincko, ginseng, green tea

61
Q

what is the MOA of Heparin

A

“indirect” agent (does not act by iteself)
binds to and activates anti-thrombin(ATIII) and increases anti-thrombin activity 1000-fold

62
Q

what does heparin/anti-thorombin complex lead to

A

inactivation of thrombin (factor IIa) and other clotting factors (IXa and Xa)

63
Q

what is the purpose of heparin

A

prevent and allow body to break down thromboembolism
PE, DVT, TIA, ACS (MI)
sometimes used initially in Afib or Prosthetic vales and hemodialysis and heart/lung bypass machines

64
Q

what are the types of heparin

A

Unfractionated and Low Molecular weight Heparin
both bind to anti-thrombin, inactivate Xa and thrombin, inhibit formation of fibrin
Injectable

65
Q

what should be avoided when using Heparin

A

NSAIDs - bleeding and renal dysfunction risks

66
Q

what is the unset of unfractionated heparin

A

rapid onset with a short half life

67
Q

how is unfractionated heparin administered

A

Infuse or subQ

68
Q

what are the side effects of unfractionated heparin

A

bleeding
osteoporosis
hyperkalemia (via aldosterone suppression)
elevation in transaminases (transient)

69
Q

what is HIT

A

Heparin induce thrombocytopenia

70
Q

what is a risk of unfractionated heparin

A

HIT (heparin induced thrombocytopenia)
immune mediated, life threatening disease state
increased risk for clotting
STOP heparin ASAP and start alternative anticoagulant

71
Q

what is the antidote to unfractionated heparin

A

Protamine sulfate
- although rarely used due to short half life of heparin except after bypass surgery

72
Q

LMWH have lower risk for

A

HIT and osteoporosis

73
Q

when is LMWH contraindicated

A

do not use if spinal or epidural catheters, use 4 hours after removal - prevents spinal hematoma

74
Q

what are the different types of LMWH

A

Enoxaparin (lovenox)
Dalteparin (Fragmin)
Tinzaparin (Innohep)

75
Q

what needs to be checked regularly in patients on heparin

A

Platelets checked daily or multiple times a day to ensure HIT does not take place

76
Q

what is the indications for enoxaparin (Lovenox)

A

DVT/PE treatement and DVT prophylaxis in knee/hip replacement and abdominal surgerys
prophylactic anticoag for immobilized

77
Q

what are the adverse effects of lovenox

A

peripheral edema

78
Q

when is Dalteparin used

A

primarily in patients with malignancy, more effective than warfarin in reducing risk of recurrent embolic events

79
Q

what are the risks of Tinzaparin

A

increased risk of death in elderly, especially if renal insufficiency in DVT, PE or both

80
Q

what is the MOA of Warfarin

A

inhibition of Vitamin K
inhibits formation of fibrin

81
Q

what is the importance of Vitamin K

A

co-factor in carboxylation/activation of several clotting factors (factor II, VII, IX and X)

82
Q

what needs to be monitored with warfain use

A

PT/INR

83
Q

what medication is weight base and also safe with pregnancy

A

Enoxaparin

84
Q

what does warfarin bind to

A

albumin - rapid absorption

85
Q

what can reverse warfain

A

Vitamin K infusion

86
Q

what drugs increase bleeding/potentiate Warfarin activity

A

ASA - inhibition of platelets
Heparin - inhibits clotting factors
Antibiotics - cut bacteria Vit K production

87
Q

what drugs decrease warfarin activity

A

barbiturates, phenytoin - induction of metabolizing enzymes
Vitamin K - promote clotting factor synthesis
Cholestyramine - reduce absorption

88
Q

what medication is used as a bridge for coumadin therapeutic onset

A

enoxaprin (lovenox)

89
Q

what are the indications of Warfarin use

A

DVT/PE treatment - prevent clot from growing while the body dissolves the plug
Prophylaxis thrombic event in: Afib, atrial flutter, prosthetic heart vales, recurrent DVT, perioperative (TKA,THA)

90
Q

what is the INR goal range

A

1.0 - 3.0 for most

91
Q

what is the INR goal for mechanical valve patients

A

2.5-3.5

92
Q

what is Dabigatran (pradaxa)

A

direct anti-thrombic agent
first warfarin alternative
“not inferior to warfarin in preventing CVA”

93
Q

what are the adverse effects of Dabigatran

A

bleeding (more GI)

94
Q

what is the antidote for Dabigatran

A

Idarucizumab (Praxbind) - monocolonal antibody that removes dabigatran

95
Q

what can happen with the discontinuation of dabigatran

A

can cause rebound thrombosis

96
Q

what is Argatroban (Acova)

A

direct thrombin inhibitor
- binds to thrombin, inhibits converstion to fibrinogen ->fibrin
IV only

97
Q

what is Argatroban used for

A

anticoagulant prophylaxis or treatment for HIT
also used in PCI if patient is at risk of HIT with heparin agent

98
Q

what needs to be monitored when taking Argatroban

A

ACT (active clotting time) and in patients with hepatic impairment (dose should be decreased)

99
Q

What are Factor Xa Inhibitors / DOAC

A

Fondaparinux (arixtra) injection
Rivaroxaban (Xarelto) oral
Apixaban (eliquis) oral

100
Q

what is the MOA for fonduparinux

A

binds to anti-thrombin III, consider as an alternative to heparin in pts with history of HIT
No binding to Plasma protein - no direct effect on thrombin

101
Q

what is the use for fonduparinux

A

prevent DVT in orthopedic surgery and treatment for PE/DVT

102
Q

what is Rivaroxaban used for

A

DVT/PE prevention and treatment and stroke prevention in non-valvular Afib

103
Q

what are the risks of Rivaroxaban

A

highest risk of GI bleeding of the Factor Xa inhibitors, more liver/kidney risk

lower risk of serious and fatal bleeding events than warfarin

104
Q

what is apixaban used for

A

DVT/PE prevention after THA/TKA
effective in stroke prevention in non-valvular Afib
better than warfarin, less bleeding

105
Q

what is the MOA for fibrinolysis

A

medically-induced degradation of clots
- activation of endogenous protease
- plasminogen activated to plasmin
- plasmin breaks down fibrin clots

106
Q

when are fibrinolytics more effective

A

against new formed thrombi in acute MRI, Aterial and venous thrombosis and PE

107
Q

what are the risks of Fibrinolytics

A

hemorrhage by destruction of therapeutic clots as well as pathologic clots

108
Q

what are the types of Fibrinolytic drugs

A

Anisterplase
Urokinase
Alteplase (tPA)

109
Q

what is Antisterplase

A

plasminogen/streptokinase activator complex
purified human plasminogen and bacterial streptokinase that has been acylated to protect the enzyme’s active site

110
Q

what is the MOA for anisterplase

A

catalyzes conversion of inactive plasminogen to plasmin - combines with pro-activator plaminogen

111
Q

what are the risks of antistreplast

A

high indiscriminate bleeding

112
Q

what is urokinase

A

from urine, similar to streptokinase
only indicated for PE
neither used much anymore

113
Q

what is tPA

A

endogenous activator of plasminogen to plasmin converstion
preferentially activates plaminogen bound to fibrin
produces by recombinant DNA technology

114
Q

what does tPA stand for

A

tissue plasminogen activator

115
Q

what is reteplase (r-PA)

A

genetically engineered, similar derivative of tPA = faster and more potent
administered IV for acute MI - off label for massive PE and DVT

116
Q

what is tenecteplast (TNK-tPA)

A

genetically engineered, smaller derivative of tPA
longer half life than rPA
higher affinity for fibrin than alteplase
administered IV for acute MI - off label for massive PE and DVT